Document Detail

Medical and revascularization management in acute coronary syndrome in renal patients.
MedLine Citation:
PMID:  11172556     Owner:  NLM     Status:  MEDLINE    
Despite the high incidence of coronary artery disease in patients with renal impairment, its diagnosis and management remains difficult. The treatment of acute coronary syndrome in this particular group of patients is more complex than in patients with normal renal function. They have a high prevalence of asymptomatic cardiac ischemia. Abnormal baseline electrocardiogram (ECG) findings and nonspecific elevation of cardiac enzymes may be present. Studies are lacking regarding their management mainly because they have been excluded or were not studied as a subgroup in the clinical trials. Thrombolytics are underused during acute myocardial infarction. Heparin, mainly low-molecular weight heparin, for unstable angina and non-Q wave myocardial infarction, should be used with caution because the higher risk for bleeding. Other medications, such as aspirin, metoprolol, and nitroglycerin should be used as in the general population. The newer platelet glycoprotein IIb/IIIa inhibitors may need renal dose adjustment. Revascularization should be pursued if necessary by percutaneous coronary intervention or coronary artery bypass grafting. However, the prognosis and risk of revascularization versus medical therapy have not been determined yet.
J S Fernandez; A Sadaniantz
Related Documents :
19840566 - Comparison of bivalirudin monotherapy versus unfractionated heparin plus tirofiban in p...
12783606 - Evolving role of bivalirudin in percutaneous coronary interventions; impact of the repl...
22363556 - A randomly-controlled study on the cardiac function at the early stage of return to the...
15820166 - Compliance as a critical consideration in patients who appear to be resistant to aspiri...
16864956 - Long-term effects of cardiac resynchronization therapy on heart rate and heart rate var...
6481876 - Differential management of acute peripheral arterial ischemia.
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Seminars in nephrology     Volume:  21     ISSN:  0270-9295     ISO Abbreviation:  Semin. Nephrol.     Publication Date:  2001 Jan 
Date Detail:
Created Date:  2001-01-31     Completed Date:  2001-05-24     Revised Date:  2005-11-16    
Medline Journal Info:
Nlm Unique ID:  8110298     Medline TA:  Semin Nephrol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  25-35     Citation Subset:  IM    
Brown University School of Medicine and the Coronary Care Unit, The Miriam Hospital, Providence, RI, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Acute Disease
Combined Modality Therapy
Coronary Disease / diagnosis,  etiology,  therapy*
Kidney Failure, Chronic / complications*
Myocardial Revascularization / methods
Risk Factors

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Diagnostic tools and management strategies for coronary artery disease in patients with end-stage re...
Next Document:  Renal implications of percutaneous coronary intervention.